These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2340315)

  • 1. [Components of human complement system. Testing and isolation of C3 and C5].
    Kosiak AV; Shukun SA; Poddubkova TN; Chikh VP; Surovtsev VI
    Biokhimiia; 1990 Feb; 55(2):276-84. PubMed ID: 2340315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Components of human complement system. Testing and isolation of C4].
    Chikh VP; Kosiak AV; Shukun SA; Surovtsev VI
    Biokhimiia; 1990 Mar; 55(3):404-7. PubMed ID: 2354211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on C3-like factor in the serum of a C3-deficient subject.
    Kitamura H; Nishimukai H; Sano Y; Nagaki K
    Immunology; 1984 Feb; 51(2):239-45. PubMed ID: 6693133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of human complement factors C3, C5 and H.
    Lundwall A; Eggertsen G
    J Immunol Methods; 1985 Jul; 81(1):147-60. PubMed ID: 3160789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large scale isolation of functionally active components of the human complement system.
    Hammer CH; Wirtz GH; Renfer L; Gresham HD; Tack BF
    J Biol Chem; 1981 Apr; 256(8):3995-4006. PubMed ID: 6783652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid isolation and characterization of native mouse complement components C3 and C5.
    Van den Berg CW; Van Dijk H; Capel PJ
    J Immunol Methods; 1989 Aug; 122(1):73-8. PubMed ID: 2760478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of the fifth component of the bovine complement system.
    Aston WP; Mhatre A; Macrae J
    Vet Immunol Immunopathol; 1990 Apr; 24(4):301-12. PubMed ID: 2140216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation of lyophilized reagents for determining the functional activity of complement C1, C2, C3, C4 and C5 components].
    Nikiforova TV; Kuznetsova NN; Vavilova LM
    Lab Delo; 1988; (3):28-31. PubMed ID: 2453712
    [No Abstract]   [Full Text] [Related]  

  • 10. Identity of C3- and C5-receptors on lymphoid cells.
    Landen B; Dierich MP
    J Immunol; 1979 Mar; 122(3):1015-7. PubMed ID: 448068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
    Kitamura H; Tsuboi M
    Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural homologies of component C5 of human complement with components C3 and C4 by neutron scattering.
    Perkins SJ; Smith KF; Nealis AS; Lachmann PJ; Harrison RA
    Biochemistry; 1990 Feb; 29(5):175-80. PubMed ID: 2322569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fractionation of human plasma proteins. II. The purification of human complement proteins C3, C3u, and C5 by application of affinity chromatography.
    DiScipio RG; Sweeney SP
    Protein Expr Purif; 1994 Apr; 5(2):170-7. PubMed ID: 8054851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
    Low PJ; Ai R; Ogata RT
    J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of C3, C5, and C5a functional activities by a new radiolabeling method; demonstration of C5 products in complement-activated serum.
    Kreutzer DL; Kunkel S; Ward PA; Showell H; McLean RH
    J Immunol; 1979 Nov; 123(5):2278-82. PubMed ID: 489983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of the fourth, second and fifth components of mouse complement.
    Fukuoka Y; Seino J; Okuda T; Tachibana T
    Immunology; 1984 Mar; 51(3):493-501. PubMed ID: 6698577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune system and ulcerative colitis activity. II. Complement level.
    Hermanowicz A; Sliwiński Z; Nawarska Z; Banaś B
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):509-14. PubMed ID: 6152530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial characterization of procomplementary activity of porcine serum and its relationship to the fifth component of complement.
    Jensen MT; Stone SS
    Am J Vet Res; 1981 Dec; 42(12):2071-3. PubMed ID: 6176150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death.
    Drake WP; Pokorney DR; Kopyta LP; Mardiney MR
    Biomedicine; 1976 May; 25(3):91-4. PubMed ID: 949521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.